Dave A. Miller, Ph.D.
Affiliations: | 2007 | Pharmaceutics | University of Texas at Austin, Austin, Texas, U.S.A. |
Area:
PharmacyGoogle:
"Dave Miller"Parents
Sign in to add mentor| James W. McGinity | grad student | 2007 | UT Austin | |
| (Improved oral absorption of poorly water -soluble drugs by advanced solid dispersion systems.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Thompson SA, Gala U, Davis DA, et al. (2023) Can the Oral Bioavailability of the Discontinued Prostate Cancer Drug Galeterone Be Improved by Processing Method? KinetiSol® Outperforms Spray Drying in a Head-to-head Comparison. Aaps Pharmscitech. 24: 137 |
| Thompson SA, Davis DA, Miller DA, et al. (2023) Pre-Processing a Polymer Blend into a Polymer Alloy by KinetiSol Enables Increased Ivacaftor Amorphous Solid Dispersion Drug Loading and Dissolution. Biomedicines. 11 |
| Corum I, Spangenberg A, Miller K, et al. (2023) Minimization of Acid-Catalyzed Degradation in KinetiSol Processing through HPMCAS Neutralization. Molecular Pharmaceutics |
| Davis DA, Miller DA, Santitewagun S, et al. (2021) Formulating a heat- and shear-labile drug in an amorphous solid dispersion: Balancing drug degradation and crystallinity. International Journal of Pharmaceutics: X. 3: 100092 |
| Gala UH, Miller DA, Su Y, et al. (2021) The Effect of Drug Loading on the Properties of Abiraterone-Hydroxypropyl Beta Cyclodextrin Solid Dispersions Processed by Solvent Free KinetiSol® Technology. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V |
| Davis DA, Miller DA, Su Y, et al. (2020) Thermally Conductive Excipient Expands KinetiSol® Processing Capabilities. Aaps Pharmscitech. 21: 319 |
| Tan DK, Davis DA, Miller DA, et al. (2020) Innovations in Thermal Processing: Hot-Melt Extrusion and KinetiSol® Dispersing. Aaps Pharmscitech. 21: 312 |
| Jermain SV, Lowinger MB, Ellenberger DJ, et al. (2020) and behavior of KinetiSol® and spray dried amorphous solid dispersions of a weakly basic drug and ionic polymer. Molecular Pharmaceutics |
| Gala U, Miller D, Williams RO. (2020) Improved Dissolution and Pharmacokinetics of Abiraterone through KinetiSol Enabled Amorphous Solid Dispersions. Pharmaceutics. 12 |
| Gala UH, Miller DA, Williams RO. (2019) Harnessing the therapeutic potential of anticancer drugs through amorphous solid dispersions. Biochimica Et Biophysica Acta. Reviews On Cancer. 188319 |